company background image
CHE logo

Chemed NYSE:CHE Stock Report

Last Price

US$593.39

Market Cap

US$8.7b

7D

-0.7%

1Y

-4.1%

Updated

13 Apr, 2025

Data

Company Financials +

Chemed Corporation

NYSE:CHE Stock Report

Market Cap: US$8.7b

CHE Stock Overview

Provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. More details

CHE fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance5/6
Financial Health6/6
Dividends0/6

Rewards

Trading at 38.7% below our estimate of its fair value

Earnings are forecast to grow 9.57% per year

Earnings have grown 1.1% per year over the past 5 years

Risk Analysis

Significant insider selling over the past 3 months


Chemed Corporation Competitors

DaVita

NYSE:DVA

US$12.4b

CorVel

NasdaqGS:CRVL

US$6.0b

Option Care Health

NasdaqGS:OPCH

US$5.2b

Labcorp Holdings

NYSE:LH

US$18.5b

Price History & Performance

Summary of share price highs, lows and changes for Chemed
Historical stock prices
Current Share PriceUS$593.39
52 Week HighUS$625.09
52 Week LowUS$512.12
Beta0.49
1 Month Change-0.81%
3 Month Change11.94%
1 Year Change-4.06%
3 Year Change19.01%
5 Year Change31.60%
Change since IPO5,145.44%

Recent News & Updates

Here's Why We Think Chemed (NYSE:CHE) Is Well Worth Watching

Apr 07
Here's Why We Think Chemed (NYSE:CHE) Is Well Worth Watching

Chemed Corporation's (NYSE:CHE) Intrinsic Value Is Potentially 61% Above Its Share Price

Mar 21
Chemed Corporation's (NYSE:CHE) Intrinsic Value Is Potentially 61% Above Its Share Price

Recent updates

Here's Why We Think Chemed (NYSE:CHE) Is Well Worth Watching

Apr 07
Here's Why We Think Chemed (NYSE:CHE) Is Well Worth Watching

Chemed Corporation's (NYSE:CHE) Intrinsic Value Is Potentially 61% Above Its Share Price

Mar 21
Chemed Corporation's (NYSE:CHE) Intrinsic Value Is Potentially 61% Above Its Share Price

Chemed Corporation's (NYSE:CHE) Popularity With Investors Is Clear

Mar 06
Chemed Corporation's (NYSE:CHE) Popularity With Investors Is Clear

Investors Shouldn't Overlook The Favourable Returns On Capital At Chemed (NYSE:CHE)

Jan 03
Investors Shouldn't Overlook The Favourable Returns On Capital At Chemed (NYSE:CHE)

With EPS Growth And More, Chemed (NYSE:CHE) Makes An Interesting Case

Dec 18
With EPS Growth And More, Chemed (NYSE:CHE) Makes An Interesting Case

Is There An Opportunity With Chemed Corporation's (NYSE:CHE) 25% Undervaluation?

Dec 03
Is There An Opportunity With Chemed Corporation's (NYSE:CHE) 25% Undervaluation?

The Chemed Corporation (NYSE:CHE) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Nov 01
The Chemed Corporation (NYSE:CHE) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Chemed Corporation's (NYSE:CHE) Business Is Yet to Catch Up With Its Share Price

Oct 29
Chemed Corporation's (NYSE:CHE) Business Is Yet to Catch Up With Its Share Price

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Aug 26
Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future
author-image

Strategic Acquisitions And Operational Efficiencies Set To Propel VITAS And Roto-Rooter Forward

Aug 25 Strategic acquisitions, such as Covenant Health, and aggressive hiring in VITAS are poised to enhance Chemed's revenue and net margins through improved operational efficiency.

Chemed Remains A Buy On Long-Term Economics

Aug 16

Chemed Corporation's (NYSE:CHE) Shares May Have Run Too Fast Too Soon

Jul 19
Chemed Corporation's (NYSE:CHE) Shares May Have Run Too Fast Too Soon

Chemed: Growth Does Not Justify The Current Stock Price

May 20

Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

May 14
Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Apr 26
Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Chemed: Continues To Compound Shareholder Value At Double-Digit Returns

Nov 30

Chemed - Showcasing Why It's So Reliable

Aug 26

Chemed: Still Bullish On Economic Characteristics, But Risks Shouldn't Be Overlooked

Aug 13

Shareholder Returns

CHEUS HealthcareUS Market
7D-0.7%9.3%5.8%
1Y-4.1%12.9%4.8%

Return vs Industry: CHE underperformed the US Healthcare industry which returned 13.6% over the past year.

Return vs Market: CHE underperformed the US Market which returned 3.6% over the past year.

Price Volatility

Is CHE's price volatile compared to industry and market?
CHE volatility
CHE Average Weekly Movement3.8%
Healthcare Industry Average Movement7.4%
Market Average Movement7.7%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market4.1%

Stable Share Price: CHE has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: CHE's weekly volatility (4%) has been stable over the past year.

Community vs My Fair Value

Select a narrative for quick price alerts from the community, or create your own.

CHE logo
Chemed
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts

VITAS's Expansion In Florida Will Tap Favorable Demographics In Retirement Communities

Key Takeaways The acquisition of Covenant Health and Florida expansion are driving significant growth and revenue projections for VITAS, leveraging demographic advantages. Roto-Rooter's innovations and conversion improvements aim to reverse revenue declines and enhance earnings potential in residential services.
View narrative
US$675.00
FV
12.1% undervalued intrinsic discount
6.90%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
4 days ago author updated this narrative
View Chemed Community

About the Company

FoundedEmployeesCEOWebsite
197015,695Kevin McNamarawww.chemed.com

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Chemed Corporation Fundamentals Summary

How do Chemed's earnings and revenue compare to its market cap?
CHE fundamental statistics
Market capUS$8.69b
Earnings (TTM)US$302.00m
Revenue (TTM)US$2.43b

28.8x

P/E Ratio

3.6x

P/S Ratio

Is CHE overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CHE income statement (TTM)
RevenueUS$2.43b
Cost of RevenueUS$1.58b
Gross ProfitUS$854.35m
Other ExpensesUS$552.35m
EarningsUS$302.00m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

Apr 23, 2025

Earnings per share (EPS)20.63
Gross Margin35.14%
Net Profit Margin12.42%
Debt/Equity Ratio0%

How did CHE perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

9%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/13 04:38
End of Day Share Price 2025/04/11 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Chemed Corporation is covered by 12 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ishan MajumdarBaptista Research
Adam FeinsteinBarclays
Joanna Sylvia GajukBofA Global Research